The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) defines nonalcoholic fatty liver disease (NAFLD) as an overarching term for a set of diseases that cause a fat buildup in...
In a recent press release, Ardelyx announced the results of a survey on dialysis patients in collaboration with the National Kidney Foundation. The survey revealed that the majority, 80%, of patients...
On October 11, 2022, the United States Preventative Service Task Force (USPSTF) released a recommendation in JAMA Network Open advising that all adolescents between 8 and 18 years old receive anxiety...
A Quest Diagnostics Health Trends study analyzed the rates of breast and prostate cancer diagnosis to find that the rates still lag behind pre-pandemic diagnoses. The American Society of Clinical...
In a recent press release, Abbott announced that the results from a study published in the New England Journal of Medicine show that their glucose monitoring device, the FreeStyle Libre 2 system,...
In a press statement released on October 3, 2022, the Nevro Corporation announced that the American Society of Clinical Endocrinology (AACE) updated its clinical practice guidelines for diabetic...
In the spring of 2021, the CuRe trial — also known as the Cellular Therapy for In Utero Repair of Myelomeningocele trial — was launched by UC Davis Health. Through this trial, 35 patients...
Theranica is an organization that develops bio-electrics for safe pain management. In a recent press release, the organization announced clinical trial results, published in the Journal of Pain...
On September 13, 2022, Silent Night Therapy announced a new remote patient monitoring technology for sleep apnea. This technology could revolutionize sleep apnea testing, which currently requires...
On September 16, 2022, the FDA granted bluebird bio accelerated approval for their gene therapy technology, Skysona. This technology is meant to treat active cerebral adrenoleukodystrophy (CALD) in...
On September 19, 2022, the FDA granted Advanced NanoTherapies a Breakthrough Device Designation (BDD) for its SirPlux Duo Drug-Coated Balloon (DCB) to treat coronary artery disease. Based on the press...
A retrospective cohort study using data from the National Cancer Database from January 2004 to December 2019 examined trends in postoperative intensity modulated radiation therapy (IMRT) and the...
A recent publication in JAMA Otolaryngology-Head and Neck Surgery analyzed the outcomes of temperature-controlled radiofrequency (TCRF) device treatment for patients with nasal airway obstruction...
It is widely agreed upon that a healthy lifestyle, including healthy dietary choices and regular activity, improves overall well-being and can reduce mortality risk. A recent publication in JAMA...
Researchers published an article in the Journal of the American Heart Association (JAHA) stating that atrial cardiopathy may be associated with increased dementia risk. Data from the WHO suggests that...
According to the CDC, as of 2020, approximately 7.8% of the general population in the United States has asthma. It was previously understood that Black and Hispanic pediatric patients had higher asthma...
A study published in Translational Vision Science and Technology using data from the New York Eye and Ear Infirmary of Mount Sinai (NYEE) found that following a glaucoma diagnosis, Black patients were...
On Monday, July 11, Athos therapeutics announced its plans for a research collaboration with Lahey Hospital and Medical Center in Burlington, Massachusetts, for precision medicine in inflammatory bowel...
A study published in JAMA found that a reduction in muscle strength is associated with an increased risk of dementia. Researchers in this study analyzed data from the UK Biobank on patients between 39...
After obtaining FDA approval on May 31, 2022, the next-generation continuous glucose monitor (CGM) system FreeStyle Libre 3 has garnered another major win for its manufacturer, Abbott.
Clinical data...
